Cargando…
Denosumab for dialysis patients with osteoporosis: A cohort study
Evidence for the efficacy of denosumab in HD patients is limited. Accordingly, here we report a study on the safety and efficacy of denosumab in these patients. We prospectively followed 324 patients (121 HD and 203 non-HD patients) receiving denosumab between June 2013 and May 2018, assessing chang...
Autores principales: | Kunizawa, Kyohei, Hiramatsu, Rikako, Hoshino, Junichi, Mizuno, Hiroki, Ozawa, Yuko, Sekine, Akinari, Kawada, Masahiro, Sumida, Keiichi, Hasegawa, Eiko, Yamanouchi, Masayuki, Hayami, Noriko, Suwabe, Tatsuya, Sawa, Naoki, Ubara, Yoshifumi, Takaichi, Kenmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016112/ https://www.ncbi.nlm.nih.gov/pubmed/32051451 http://dx.doi.org/10.1038/s41598-020-59143-8 |
Ejemplares similares
-
Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report
por: Kunizawa, Kyohei, et al.
Publicado: (2018) -
Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
por: Mizuno, Hiroki, et al.
Publicado: (2017) -
Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis
por: Ikuma, Daiuske, et al.
Publicado: (2019) -
Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders
por: Oshima, Yoichi, et al.
Publicado: (2020) -
Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus
por: Shima, Natsuki, et al.
Publicado: (2018)